258 related articles for article (PubMed ID: 15899439)
1. Slitlamp biomicroscopy of the tear film of patients using topical Restasis and Refresh Endura.
Solomon R; Perry HD; Donnenfeld ED; Greenman HE
J Cataract Refract Surg; 2005 Apr; 31(4):661-3. PubMed ID: 15899439
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
Di Pascuale MA; Goto E; Tseng SC
Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness.
Scaffidi RC; Korb DR
Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677
[TBL] [Abstract][Full Text] [Related]
4. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
5. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.
Sall KN; Cohen SM; Christensen MT; Stein JM
Eye Contact Lens; 2006 Jan; 32(1):21-6. PubMed ID: 16415689
[TBL] [Abstract][Full Text] [Related]
7. Effect of castor oil emulsion eyedrops on tear film composition and stability.
Maïssa C; Guillon M; Simmons P; Vehige J
Cont Lens Anterior Eye; 2010 Apr; 33(2):76-82. PubMed ID: 19963428
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
Willen CM; McGwin G; Liu B; Owsley C; Rosenstiel C
Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
[TBL] [Abstract][Full Text] [Related]
9. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
Ousler GW; Michaelson C; Christensen MT
Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
[TBL] [Abstract][Full Text] [Related]
11. An interferometric method for the dynamic evaluation of the tear film.
Szczesna DH; Kasprzak HT; Jaronski J; Rydz A; Stenevi U
Acta Ophthalmol Scand; 2007 Mar; 85(2):202-8. PubMed ID: 17305735
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
J Cataract Refract Surg; ; . PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
